FIELD: pharmacology.
SUBSTANCE: invention concerns novel compounds of formula (1a), formula (1b), formula (1c) and formula (1d), as well as pharmaceutical composition based on them and their application in medicine obtainment.
R1-R4, G, W, X, X1, U, V, a, b are defined in the invention claim.
EFFECT: compound with antagonistic effect on vasopressin V1A receptor.
73 cl, 133 ex
Title | Year | Author | Number |
---|---|---|---|
PYRAZOLOPYRIMIDINE DERIVATIVE | 2007 |
|
RU2420530C2 |
BENZAMIDE DERIVATIVES AS OXYTOCIN AGONISTS AND VASOPRESSIN ANTAGONISTS | 2004 |
|
RU2340617C2 |
PIPERIDINE DERIVATIVE | 2008 |
|
RU2475485C2 |
BENZOXEPIN PI3 INHIBITORS AND METHODS FOR USING THEM | 2010 |
|
RU2557658C2 |
NEW CYCLIC DINUCLEOTIDE DERIVATIVE AND ITS ANTIBODY-DRUG CONJUGATE | 2019 |
|
RU2809547C2 |
AMINOPROPYLIDENE DERIVATIVES | 2009 |
|
RU2483063C2 |
BICYCLIC HETEROCYCLE COMPOUNDS AND THEIR USES IN THERAPY | 2012 |
|
RU2662827C2 |
ETHYNYL DERIVATIVES | 2016 |
|
RU2722014C2 |
BENZOXAZEPINE PI3 INHIBITORS AND METHODS OF USE | 2010 |
|
RU2654068C1 |
TRICYCLIC PYRAZOLOPYRIMIDINE DERIVATIVE | 2010 |
|
RU2520966C2 |
Authors
Dates
2009-10-20—Published
2005-08-24—Filed